Release Date: 08/23/2004

Title:  Databeacon cures Sales Reporting ailments for the Harvard Drug Group

Abstract:  Web reporting and data analysis solution cuts an estimated 700 plus employee hours per year

OTTAWA, ON – August 23, 2004 - Databeacon Inc., a developer of Web reporting and data analysis software, today announced it has been selected by the Harvard Drug Group, a secondary brand wholesaler and generic drug and consumer products distributor, to provide robust sales reporting and data analysis capabilities. This win is a result of Databeacon partner Subject, Wills & Company. To date, the Databeacon implementation has already helped the Harvard Drug Group significantly reduce the time needed to develop daily and month-end sales and management reports.

With three products lines and three operating warehouses located across the country, the Harvard Drug Group needed to replace its outdated Cognos system, which provided limited data access and could not meet the company’s growing demands. The Harvard Drug Group chose Databeacon software for its ease of use, Web-based functionality, and affordable licensing structure.

Now, instead of spending numerous hours to manually input data, the management team can develop daily sales reports in under 30 minutes and monthly reports within an hour. Additionally, using Databeacon software, the Harvard Drug Group has reduced an estimated 700 plus hours of manual data entry per year, enabling employees to focus on more strategic activities.

“With Databeacon we can slice, dice and deliver our sales data in any way, based on what each individual wants,” said Debbie Larsen, Director of Sales Operations for the Harvard Drug Group. “If we need to see the data in a whole new way, there’s no waiting or going back to IT, we just do it ourselves.”

The features of Databeacon software – ease of use, fast deployment, implementation speed and low cost of ownership – are designed for mid-market organizations like the Harvard Drug Group, whose needs are not met by the often complex and expensive products offered by many of its competitors.

“Many companies struggle with ineffective data analysis tools that are difficult to use and expensive to maintain,” said Andy Coutts, President and CEO of Databeacon. “Our relationship with the Harvard Drug Group is a testament to Databeacon’s ability to provide mid-market organizations with simple, comprehensive, and affordable Web reporting and data analysis functionality that can positively impact business performance.”

About the Harvard Drug Group, LLC
The Harvard Drug Group is uniquely positioned as a secondary brand wholesaler and generic drug and consumer products distributor. From behind the counter to the front of the store, The Harvard Drug Group and Major Pharmaceuticals supplies Rx brands, generics and consumer products to retail, medical professionals and managed care providers throughout the US.

About Subject, Wills & Company
Since its inception in 1980, Subject, Wills & Company has earned a solid reputation as a leading technology solutions provider, dedicated to helping clients achieve superior business results through the innovative and effective use of technology. Our expertise includes Security, Network Infrastructure, and development of Web-based solutions.

Subject, Wills & Company has partnered with Databeacon to leverage their Web-based Analysis and Reporting solutions. Together, they work as a team, transforming unique business challenges into opportunities for greater insight, productivity and profitability for clients.

About Databeacon Inc.
Databeacon, a Cognos Company, combines Business Analytics and Reporting in the form of self-serve, explorable reports via no-touch deployments. The company has more than 1,100 customers and 110 reseller and OEM/ISV partners worldwide trained to both advise on and implement Business Analytics and Reporting projects.

For more information, please contact:
Steve Reside
Marketing Manager
Databeacon Inc.
613-738-2132
Steve.Reside@cognos.com